journal article·2024-08-12

Endogenous Tissue Engineering for Chondral and Osteochondral Regeneration: Strategies and Mechanisms

Yanan Zhang, Jialin Chen, Yuzhi Sun, Mingyue Wang, Haoyang Liu, Wei Zhang

Publisher page

Abstract

Increasing attention has been paid to the development of effective strategies for articular cartilage (AC) and osteochondral (OC) regeneration due to their limited self-reparative capacities and the shortage of timely and appropriate clinical treatments. Traditional cell-dependent tissue engineering faces various challenges such as restricted cell sources, phenotypic alterations, and immune rejection. In contrast, endogenous tissue engineering represents a promising alternative, leveraging acellular biomaterials to guide endogenous cells to the injury site and stimulate their intrinsic regenerative potential. This review provides a comprehensive overview of recent advancements in endogenous tissue engineering strategies for AC and OC regeneration, with a focus on the tissue engineering triad comprising endogenous stem/progenitor cells (ESPCs), scaffolds, and biomolecules. Multiple types of ESPCs present within the AC and OC microenvironment, including bone marrow-derived mesenchymal stem cells (BMSCs), adipose-derived mesenchymal stem cells (AD-MSCs), synovial membrane-derived mesenchymal stem cells (SM-MSCs), and AC-derived stem/progenitor cells (CSPCs), exhibit the ability to migrate toward injury sites and demonstrate pro-regenerative properties. The fabrication and characteristics of scaffolds in various formats including hydrogels, porous sponges, electrospun fibers, particles, films, multilayer scaffolds, bioceramics, and bioglass, highlighting their suitability for AC and OC repair, are systemically summarized. Furthermore, the review emphasizes the pivotal role of biomolecules in facilitating ESPCs migration, adhesion, chondrogenesis, osteogenesis, as well as regulating inflammation, aging, and hypertrophy-critical processes for endogenous AC and OC regeneration. Insights into the applications of endogenous tissue engineering strategies for in vivo AC and OC regeneration are provided along with a discussion on future perspectives to enhance regenerative outcomes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Medicine, Southeast University, 210009 Nanjing, China

Jiangsu Key Laboratory for Biomaterials and Devices, Southeast University, 210096 Nanjing, China

China Orthopedic Regenerative Medicine Group (CORMed), 310058 Hangzhou, China

Department of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital, Nanjing Medical University, 210006 Nanjing, China

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Southeast University · Key Technology Research and Development Program of Shandong Province

References (100+)

Show source-provided references
1. 10.3390/pharmaceutics1307098310.3390/pharmaceutics13070983 ↗
2. 10.1016/j.biomaterials.2022.12187010.1016/j.biomaterials.2022.121870 ↗
3. 10.1016/j.actbio.2021.12.00610.1016/j.actbio.2021.12.006 ↗
4. 10.1097/BOR.000000000000047910.1097/BOR.0000000000000479 ↗
5. 10.1016/j.joca.2017.07.00410.1016/j.joca.2017.07.004 ↗
6. 10.1002/art.3946510.1002/art.39465 ↗
7. 10.1002/advs.20220005010.1002/advs.202200050 ↗
8. 10.1016/j.actbio.2017.01.03610.1016/j.actbio.2017.01.036 ↗
9. 10.1089/sur.2020.07510.1089/sur.2020.075 ↗
10. 10.1016/j.apmt.2017.12.00210.1016/j.apmt.2017.12.002 ↗
11. 10.1016/j.arthro.2012.06.00910.1016/j.arthro.2012.06.009 ↗
12. 10.1016/j.eats.2017.07.00410.1016/j.eats.2017.07.004 ↗
13. 10.1007/978-3-030-74625-4_2610.1007/978-3-030-74625-4_26 ↗
14. 10.1016/j.ijsu.2019.06.00710.1016/j.ijsu.2019.06.007 ↗
15. 10.3389/fbioe.2020.0040410.3389/fbioe.2020.00404 ↗
16. 10.1016/j.biomaterials.2020.11982110.1016/j.biomaterials.2020.119821 ↗
17. 10.1007/978-3-319-76735-2_1010.1007/978-3-319-76735-2_10 ↗
18. 10.1097/00003086-200005000-0002010.1097/00003086-200005000-00020 ↗
19. 10.1016/j.bioactmat.2022.06.01510.1016/j.bioactmat.2022.06.015 ↗
20. 10.2106/00004623-200312000-0004410.2106/00004623-200312000-00044 ↗
21. 10.1016/j.arthro.2005.06.01810.1016/j.arthro.2005.06.018 ↗
22. 10.1016/j.jconrel.2021.02.03610.1016/j.jconrel.2021.02.036 ↗
23. 10.1016/j.bioactmat.2021.05.01110.1016/j.bioactmat.2021.05.011 ↗
24. 10.1016/j.compositesb.2020.10844510.1016/j.compositesb.2020.108445 ↗
25. 10.1016/j.actbio.2019.02.04410.1016/j.actbio.2019.02.044 ↗
26. 10.1016/j.actbio.2022.11.00310.1016/j.actbio.2022.11.003 ↗
27. 10.1016/j.bioactmat.2023.03.00810.1016/j.bioactmat.2023.03.008 ↗
28. 10.1016/j.actbio.2020.07.00810.1016/j.actbio.2020.07.008 ↗
29. 10.3389/fcell.2020.0007210.3389/fcell.2020.00072 ↗
30. 10.1155/2012/97587110.1155/2012/975871 ↗
31. 10.1016/j.bone.2014.10.01410.1016/j.bone.2014.10.014 ↗
32. 10.1126/sciadv.adl223810.1126/sciadv.adl2238 ↗
33. 10.1038/s41392-023-01338-210.1038/s41392-023-01338-2 ↗
34. 10.1089/ten.teb.2013.010010.1089/ten.teb.2013.0100 ↗
35. 10.1016/j.biotechadv.2012.11.00410.1016/j.biotechadv.2012.11.004 ↗
36. 10.1016/j.jconrel.2016.01.03310.1016/j.jconrel.2016.01.033 ↗
37. 10.1016/j.biomaterials.2014.08.02010.1016/j.biomaterials.2014.08.020 ↗
38. 10.5966/sctm.2015-019210.5966/sctm.2015-0192 ↗
39. 10.1038/nrrheum.2017.18210.1038/nrrheum.2017.182 ↗
40. 10.5966/sctm.2016-004010.5966/sctm.2016-0040 ↗
41. 10.1155/2017/684372710.1155/2017/6843727 ↗
42. 10.1111/cpr.1301710.1111/cpr.13017 ↗
43. 10.1155/2012/81269310.1155/2012/812693 ↗
44. 10.1007/s00395-005-0552-510.1007/s00395-005-0552-5 ↗
45. 10.1517/14712598.6.6.56710.1517/14712598.6.6.567 ↗
46. 10.1186/s13287-015-0066-510.1186/s13287-015-0066-5 ↗
47. 10.1111/j.1582-4934.2011.01335.x10.1111/j.1582-4934.2011.01335.x ↗
48. 10.1517/14712598.2013.82315310.1517/14712598.2013.823153 ↗
49. 10.1186/s40659-021-00366-y10.1186/s40659-021-00366-y ↗
50. 10.1016/j.arthro.2015.09.01010.1016/j.arthro.2015.09.010 ↗
51. 10.1016/j.joms.2018.10.01810.1016/j.joms.2018.10.018 ↗
52. Lu L. · Stem Cell Res. Ther. · 2019 · 10 · 110.1186/s13287-018-1105-9 ↗
53. 10.1136/annrheumdis-2014-20684710.1136/annrheumdis-2014-206847 ↗
54. 10.1002/jor.2202910.1002/jor.22029 ↗
55. 10.1186/s13287-020-01885-310.1186/s13287-020-01885-3 ↗
56. 10.1002/art.2321910.1002/art.23219 ↗
57. 10.1126/sciadv.abk001110.1126/sciadv.abk0011 ↗
58. 10.1155/2020/883765410.1155/2020/8837654 ↗
59. 10.1016/j.gendis.2014.12.00310.1016/j.gendis.2014.12.003 ↗
60. 10.1002/art.2165110.1002/art.21651 ↗
61. 10.1186/scrt3110.1186/scrt31 ↗
62. 10.1038/nrrheum.2014.20010.1038/nrrheum.2014.200 ↗
63. 10.14336/AD.2020.090210.14336/AD.2020.0902 ↗
64. 10.1002/art.3461310.1002/art.34613 ↗
65. 10.1016/j.stem.2009.01.01510.1016/j.stem.2009.01.015 ↗
66. 10.1177/036354651985421910.1177/0363546519854219 ↗
67. 10.1242/jcs.0091210.1242/jcs.00912 ↗
68. 10.1089/ten.tea.2009.039810.1089/ten.tea.2009.0398 ↗
69. 10.1016/j.mtbio.2023.10074910.1016/j.mtbio.2023.100749 ↗
70. 10.1016/j.mtbio.2021.10017310.1016/j.mtbio.2021.100173 ↗
71. 10.1016/j.biomaterials.2006.01.03110.1016/j.biomaterials.2006.01.031 ↗
72. 10.1016/j.msec.2016.11.04410.1016/j.msec.2016.11.044 ↗
73. 10.1016/j.jare.2013.07.00610.1016/j.jare.2013.07.006 ↗
74. 10.1016/j.jsps.2015.03.02210.1016/j.jsps.2015.03.022 ↗
75. 10.1021/acsbiomaterials.0c0171610.1021/acsbiomaterials.0c01716 ↗
76. 10.1186/s12951-021-01230-710.1186/s12951-021-01230-7 ↗
77. 10.1016/j.cej.2020.12523210.1016/j.cej.2020.125232 ↗
78. 10.1002/anie.20170068410.1002/anie.201700684 ↗
79. 10.1016/j.biomaterials.2014.06.01910.1016/j.biomaterials.2014.06.019 ↗
80. 10.1021/bm301803310.1021/bm3018033 ↗
81. 10.3390/molecules2711363410.3390/molecules27113634 ↗
82. 10.1016/j.biomaterials.2021.12084110.1016/j.biomaterials.2021.120841 ↗
83. 10.1039/C4TA00743C10.1039/C4TA00743C ↗
84. 10.3727/096368911X56618110.3727/096368911X566181 ↗
85. 10.1002/jor.2087910.1002/jor.20879 ↗
86. 10.1039/C7TB02132A10.1039/C7TB02132A ↗
87. 10.1016/j.bioactmat.2021.07.03110.1016/j.bioactmat.2021.07.031 ↗
88. 10.1586/erd.10.1510.1586/erd.10.15 ↗
89. 10.1136/jisakos-2020-00060010.1136/jisakos-2020-000600 ↗
90. 10.1177/194760351454889010.1177/1947603514548890 ↗
91. 10.3390/fib1004003610.3390/fib10040036 ↗
92. 10.1007/s00542-019-04730-710.1007/s00542-019-04730-7 ↗
93. 10.1016/j.ijbiomac.2019.05.20410.1016/j.ijbiomac.2019.05.204 ↗
94. 10.1002/wnan.150910.1002/wnan.1509 ↗
95. 10.1021/acs.nanolett.9b0416210.1021/acs.nanolett.9b04162 ↗
96. 10.1021/acsami.6b0682510.1021/acsami.6b06825 ↗
97. 10.1080/09205063.2019.163069910.1080/09205063.2019.1630699 ↗
98. 10.1016/j.biomaterials.2004.03.00510.1016/j.biomaterials.2004.03.005 ↗
99. 10.3390/ijms22191029210.3390/ijms221910292 ↗
100. Prasad B. · J. Glob Trends Pharm. Sci. · 2014 · 5 · 1961